Missouri judge approves Bayer’s $7.25 billion Roundup settlement
On Friday, a Missouri judge granted approval to Bayer's $7.25 billion settlement with plaintiffs alleging that their weedkiller Roundup caused cancer, potentially ending a decade-long legal battle for the German company. Judge Timothy Boyer of a St. Louis state court deemed the settlement fair, reasonable, and adequate, rejecting objections that individual payouts to victims were insufficient, as previous settlements provided higher compensation.
The judge also dismissed concerns that delaying payments could prolong victims' wait times, including those with terminal cancer. Bayer faced around 65,000 claims in US state and federal courts from those claiming to have developed cancer from Roundup use at home or work. The settlement, announced in February, aimed to resolve nearly all existing and future Roundup lawsuits in the US.
Bayer CEO Bill Anderson hailed the court's final approval as a "decisive milestone" in the company's efforts to mitigate risks from pending and future litigation. The company has been embroiled in extensive litigation over Roundup, with its share price declining 46% since the $63 billion acquisition of Monsanto in 2018. While Bayer settled much of the Roundup litigation for $10.9 billion in 2020, it was unable to secure approval for a $1.25 billion settlement to address future claims.
The decision was made just five months after the US Supreme Court overturned a $1.25 million jury award for a Missouri man, John Durnell, who alleged that glyphosate exposure from Roundup caused his non-Hodgkin lymphoma. The 7-2 ruling supported Bayer's claim that a federal pesticide regulation law barred failure-to-warn claims under state law, weakening a major aspect of many lawsuits.
Christopher Seeger, a lawyer representing numerous plaintiffs, expressed optimism about distributing the settlement funds to Roundup victims as swiftly as possible. Lawyers for some plaintiffs who objected to the settlement had not yet responded to requests for comment. The settlement does not cover certain lawsuits still pending in federal court, with Bayer noting that around 200 cases are still being litigated, and that the Supreme Court's decision bolstered the company's defenses in those cases.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 2 other outlets
- Bayer’s $7.25 Billion Roundup Settlement Approved by Judge bloomberg.com
- Bayer’s $7.25B Roundup settlement approved by U.S. judge seekingalpha.com